Protein profile

PA3751

phosphoribosylglycinamide formyltransferase

Genome: NC_002516.2

Gene: purT PA3751 Structure source: AlphaFold UniProt Q9HXP3
Amino acids 393
Annotations 10
Features 21
PDB binders 8
Druggability 0.606

Overview

Basic information about this protein and its source genome.

Accession
PA3751
Gene
purT PA3751
Status
annotated
Amino acids
393
Structure source
AlphaFold

Target profile

Computed evidence for target prioritization.

Human off-target
No hit
Gut microbiome off-target
hit
Essential (DEG)
N
Localization
CytoplasmicMembrane

Selected Druggability evidence

Selected Druggability is the FPocket score chosen for ranking using the curated structure priority. The 3D viewer may show a different loaded structure, so its visible pockets can differ.

FPocket 0.606
Structure
Pocket

Sequence

Primary amino-acid sequence viewer.

Functional Annotations

Enzyme classification and Gene Ontology terms linked to this protein.

1 EC 9 GO

Enzyme Commission (EC)

1

Gene Ontology (GO)

9
  • GO:0005829 The part of the cytoplasm that does not contain organelles but which does contain other particulate matter, such as protein complexes.
  • GO:0005524 Binding to ATP, adenosine 5'-triphosphate, a universally important coenzyme and enzyme regulator.
  • GO:0000287 Binding to a magnesium (Mg) ion.
  • GO:0043815 Catalysis of the reaction: ATP + formate + N1-(5-phospho-beta-D-ribosyl)glycinamide = ADP + H+ + N2-formyl-N1-(5-phospho-beta-D-ribosyl)glycinamide + phosphate.
  • GO:0004644 Catalysis of the reaction: 10-formyltetrahydrofolate + N1-(5-phospho-D-ribosyl)glycinamide = tetrahydrofolate + N2-formyl-N1-(5-phospho-D-ribosyl)glycinamide.
  • GO:0006189 The chemical reactions and pathways resulting in the formation of IMP, inosine monophosphate, by the stepwise assembly of a purine ring on ribose 5-phosphate.
  • GO:0046872 Binding to a metal ion.
  • GO:0009152 The chemical reactions and pathways resulting in the formation of a purine ribonucleotide, a compound consisting of ribonucleoside (a purine base linked to a ribose sugar) esterified with a phosphate group at either the 3' or 5'-hydroxyl group of the sugar.
  • GO:0016742 Catalysis of the transfer of a hydroxymethyl- or formyl group from one compound (donor) to another (acceptor).

Sequence Features

Domain/signature hits from InterPro and related databases.

21 records
Show feature table
Start End DB Term Name
1 123 Gene3D G3DSA:3.40.50.20 -
124 196 FunFam G3DSA:3.30.1490.20:FF:000013 Formate-dependent phosphoribosylglycinamide formyltransferase
14 392 NCBIfam TIGR01142 phosphoribosylglycinamide formyltransferase 2
14 392 InterPro IPR005862 Formate-dependent phosphoribosylglycinamide formyltransferase
1 392 PANTHER PTHR43055 FORMATE-DEPENDENT PHOSPHORIBOSYLGLYCINAMIDE FORMYLTRANSFERASE
8 392 Hamap MF_01643 Formate-dependent phosphoribosylglycinamide formyltransferase [purT].
8 392 InterPro IPR005862 Formate-dependent phosphoribosylglycinamide formyltransferase
120 386 SUPERFAMILY SSF56059 Glutathione synthetase ATP-binding domain-like
119 308 ProSiteProfiles PS50975 ATP-grasp fold profile.
119 308 InterPro IPR011761 ATP-grasp fold
2 123 FunFam G3DSA:3.40.50.20:FF:000007 Formate-dependent phosphoribosylglycinamide formyltransferase
197 391 Gene3D G3DSA:3.30.470.20 -
19 81 Pfam PF01370 NAD dependent epimerase/dehydratase family
19 81 InterPro IPR001509 NAD-dependent epimerase/dehydratase
197 391 FunFam G3DSA:3.30.470.20:FF:000027 Formate-dependent phosphoribosylglycinamide formyltransferase
123 294 Pfam PF02222 ATP-grasp domain
123 294 InterPro IPR003135 ATP-grasp fold, ATP-dependent carboxylate-amine ligase-type
3 112 SUPERFAMILY SSF52440 PreATP-grasp domain
3 112 InterPro IPR016185 Pre-ATP-grasp domain superfamily
124 196 Gene3D G3DSA:3.30.1490.20 -
124 196 InterPro IPR013815 ATP-grasp fold, subdomain 1

3D Structure

Selected loaded structure. Experimental PDB entries may cover only a portion of the sequence; predicted models typically cover the full protein.

3D visualization script Full viewer

Loading 3D structure...

Legend High Medium Low

Structural evidence

0 + 1

Experimental PDB entries and predicted models. Click Switch to display a different structure in the viewer.

Entry Method Resolution Chain Coverage Links Status
AlphaFold PA3751
AlphaFold full sequence Viewing
Pocket details FPocket · P2Rank — toggle visibility and zoom from here, or open full viewer

Pockets (FPOCKET)

Showing top-ranked FPocket candidates by druggability. Druggability is color-coded: high (0.7 or higher), medium (0.4 to 0.69), low (below 0.4).

FPOCKET Sticks Spheres Surfaces Druggability Labels Zoom Positions
1 0.606

Ligand evidence

Ligands grouped by evidence source. PDB ligands keep the source crystal visible, and loaded crystals can be opened directly in the structure viewer.

58 records

Structural evidence inferred from similar proteins. The source crystal indicates where the ligand was observed; the UniProt column identifies the homologous protein carrying that ligand.

Show only:
Ligand Source crystal UniProt (homolog) MW · LogP · TPSA Lipinski PAINS SMILES
A12 Q5NGE8 425.2 Da LogP -1.64 TPSA 223.4 2 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
ACP P33221 505.2 Da LogP -1.52 TPSA 269.9 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
AGS P33221 523.2 Da LogP -1.51 TPSA 262.1 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
AIR A1CII2 295.2 Da LogP -1.81 TPSA 160.3 ✓ Ro5 ✓ Clean c1c(n(cn1)[C@H]2[C@@H]([C@@H]([C@H](O2)COP(=O)(…
ANP P33221 506.2 Da LogP -2.06 TPSA 281.9 3 viol. ✓ Clean c1nc(c2c(n1)n(cn2)[C@H]3[C@@H]([C@@H]([C@H](O3)…
GAR P33221 284.2 Da LogP -4.65 TPSA 177.2 ✓ Ro5 ✓ Clean C([C@@H]1[C@H]([C@H]([C@@H](O1)NC(=O)CN)O)O)OP(…
NHE A1CII2 207.3 Da LogP 0.80 TPSA 66.4 ✓ Ro5 ✓ Clean C1CCC(CC1)NCCS(=O)(=O)O
POP A0A0H3KFM7 176.0 Da LogP -2.08 TPSA 129.9 ✓ Ro5 ✓ Clean O[P@@](=O)([O-])O[P@@](=O)(O)[O-]

PDB and ChEMBL records on this protein are shown in full. ChEMBL records from similar proteins are capped at the top 100 per protein (by pchembl) and ZINC at the top 50 (Tanimoto ≥ 0.5). ADME columns are descriptor-based screening flags, not experimental toxicity results.